| Net Cash Provided by (Used in) Operating Activities |
$58,506,000 |
USD |
35% |
Q3 2025 |
Q3 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$147,195,000 |
USD |
-467% |
Q3 2025 |
Q3 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$5,207,000 |
USD |
-1021% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
816,574,472 |
shares |
|
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$144,555,000 |
USD |
134% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$75,328,000 |
USD |
60% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$114,100,000 |
USD |
25% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability |
$1,082,000 |
USD |
|
Q3 2025 |
Q3 2025 |
| Payments to Acquire Property, Plant, and Equipment |
$5,207,000 |
USD |
1021% |
Q3 2025 |
Q3 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$131,016,000 |
USD |
2.9% |
Q3 2025 |
Q3 2025 |
| Deferred Income Tax Expense (Benefit) |
$340,000 |
USD |
-100% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$70,001,000 |
USD |
34% |
Q4 2024 |
FY 2024 |
| Depreciation, Depletion and Amortization |
$743,000 |
USD |
-1.8% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$38,771,000 |
USD |
-12% |
Q4 2024 |
FY 2024 |
| Interest Expense |
$31,004,000 |
USD |
-15% |
Q3 2025 |
Q3 2025 |